158 related articles for article (PubMed ID: 3091779)
1. Mitomycin C skin toxicity studies in mice: reduced ulceration and altered pharmacokinetics with topical dimethyl sulfoxide.
Dorr RT; Soble MJ; Liddil JD; Keller JH
J Clin Oncol; 1986 Sep; 4(9):1399-404. PubMed ID: 3091779
[TBL] [Abstract][Full Text] [Related]
2. [An experimental investigation on preventive measures of skin ulcers induced by extravascular mitomycin C].
Wang GH; Chen M; Zhang XQ
Zhonghua Hu Li Za Zhi; 1995 Feb; 30(2):67-70. PubMed ID: 7664374
[TBL] [Abstract][Full Text] [Related]
3. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse.
Dorr RT; Alberts DS
Cancer Treat Rep; 1983 May; 67(5):499-501. PubMed ID: 6850665
[TBL] [Abstract][Full Text] [Related]
4. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
Dorr RT; Alberts DS
J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
[TBL] [Abstract][Full Text] [Related]
5. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
Dorr RT; Snead K; Liddil JD
Cancer; 1996 Jul; 78(1):152-6. PubMed ID: 8646711
[TBL] [Abstract][Full Text] [Related]
6. Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.
Dorr RT; Alberts DS; Einspahr J; Mason-Liddil N; Soble M
Cancer Treat Rep; 1987 Mar; 71(3):267-72. PubMed ID: 3815394
[TBL] [Abstract][Full Text] [Related]
7. Case report: topical DMSO for mitomycin-C-induced skin ulceration.
Alberts DS; Dorr RT
Oncol Nurs Forum; 1991; 18(4):693-5. PubMed ID: 1906166
[TBL] [Abstract][Full Text] [Related]
8. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherole.
Ludwig CU; Stoll HR; Obrist R; Obrecht JP
Eur J Cancer Clin Oncol; 1987 Mar; 23(3):327-9. PubMed ID: 3595692
[TBL] [Abstract][Full Text] [Related]
9. Antidote studies of vinorelbine-induced skin ulceration in the mouse.
Dorr RT; Bool KL
Cancer Chemother Pharmacol; 1995; 36(4):290-2. PubMed ID: 7628047
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin-induced skin ulcer in the piglet.
Okano T; Ohnuma T; Efremidis A; Holland JF
Cancer Treat Rep; 1983 Dec; 67(12):1075-8. PubMed ID: 6652625
[TBL] [Abstract][Full Text] [Related]
11. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse.
Dorr RT; Alberts DS; Stone A
Cancer Treat Rep; 1985 Apr; 69(4):431-7. PubMed ID: 3995512
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of doxorubicin in vitamin C or dimethyl sulfoxide against skin ulceration in the pig.
Hajarizadeh H; Lebredo L; Barrie R; Woltering EA
Ann Surg Oncol; 1994 Sep; 1(5):411-4. PubMed ID: 7850542
[TBL] [Abstract][Full Text] [Related]
13. Protection by alpha-tocopherol and dimethylsulfoxide (DMSO) against adriamycin induced skin ulcers in the rat.
Svingen BA; Powis G; Appel PL; Scott M
Res Commun Chem Pathol Pharmacol; 1981 Apr; 32(1):189-92. PubMed ID: 7291726
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent skin ulcers in mice treated with DNA binding antitumor antibiotics.
Soble MJ; Dorr RT; Plezia P; Breckenridge S
Cancer Chemother Pharmacol; 1987; 20(1):33-6. PubMed ID: 3621451
[TBL] [Abstract][Full Text] [Related]
15. Mitomycin C toxicity and pharmacokinetics in mice given sulfur nucleophiles.
Dorr RT; Alberts DS; Liddil JD
Anticancer Res; 1988; 8(4):733-7. PubMed ID: 3140711
[TBL] [Abstract][Full Text] [Related]
16. Prevention of doxorubicin-induced skin ulcers in the rat and pig with dimethyl sulfoxide (DMSO).
Desai MH; Teres D
Cancer Treat Rep; 1982 Jun; 66(6):1371-4. PubMed ID: 7083241
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds.
Dorr RT; Alberts DS
Cancer Treat Rep; 1981; 65(11-12):1001-6. PubMed ID: 7296547
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacokinetics of mitomycin C and its derivative (KW-2083)].
Fujita H
Gan To Kagaku Ryoho; 1982 Aug; 9(8):1362-73. PubMed ID: 6820913
[TBL] [Abstract][Full Text] [Related]
19. Semisolid formulations containing dimethyl sulfoxide and alpha-tocopherol for the treatment of extravasation of antiblastic agents.
Casiraghi A; Ardovino P; Minghetti P; Botta C; Gattini A; Montanari L
Arch Dermatol Res; 2007 Jul; 299(4):201-7. PubMed ID: 17370081
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of mitomycin-C in plasma and tumor tissue of cervical cancer patients and in selected tissues of female rats.
Malviya VK; Young JD; Boike G; Gove N; Deppe G
Gynecol Oncol; 1986 Oct; 25(2):160-70. PubMed ID: 3019843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
